Papers/PMID:39683510
Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.
Nutrients2024The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
Zn(2+) — no detected effect on adverse event occurrence (oral or enteral supplement)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The meta-analysis of adverse event rates showed no statistically significant difference between the zinc supplementation group and the placebo group (odds ratio [OR] = 2.536; 95% CI = 0.78 to 8.26; p = 0.122; I2 = 0%) Figure 9.”
Quoted verbatim from Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Women aged 13 to 27 years with primary dysmenorrhea; pooled across six randomised trials of zinc supplementation (gluconate or sulfate) against placebo
Effect 2.536 odds ratio, 95% CI 0.78 to 8.26
Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.2024PMID:39683510Industry fundedPermalink